{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T13:33:25Z","timestamp":1788183205431,"version":"build-2803163510"},"reference-count":60,"publisher":"Public Library of Science (PLoS)","issue":"6","license":[{"start":{"date-parts":[[2016,6,9]],"date-time":"2016-06-09T00:00:00Z","timestamp":1465430400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0157389","type":"journal-article","created":{"date-parts":[[2016,6,9]],"date-time":"2016-06-09T19:30:34Z","timestamp":1465500634000},"page":"e0157389","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":40,"title":["Association between High Serum Homocysteine Levels and Biochemical Characteristics in Women with Polycystic Ovarian Syndrome: A Systematic Review and Meta-Analysis"],"prefix":"10.1371","volume":"11","author":[{"given":"Yuming","family":"Meng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiang","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zheng","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuexiang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yifan","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shengming","family":"Dai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2016,6,9]]},"reference":[{"issue":"6","key":"ref1","first-page":"2745","article-title":"The prevalence and features of the polycystic ovary syndrome in an unselected population","volume":"89","author":"R Azziz","year":"2004"},{"issue":"9588","key":"ref2","first-page":"685","article-title":"Polycystic ovary syndrome","volume":"370","author":"RJ Norman","year":"2007"},{"issue":"2","key":"ref3","first-page":"90","article-title":"Long term health consequences of polycystic ovarian syndrome: a review analysis","volume":"13","author":"A Daniilidis","year":"2009"},{"issue":"3","key":"ref4","first-page":"186","article-title":"Homocysteine metabolism in polycystic ovary syndrome","volume":"28","author":"EE Grodnitskaya","year":"2012"},{"issue":"47\u201348","key":"ref5","first-page":"745","article-title":"Homocysteine as a risk factor for cardiovascular disease: should we (still) worry about?","volume":"136","author":"D Faeh","year":"2006"},{"issue":"8","key":"ref6","first-page":"1485","article-title":"Toxic effects of mildly elevated homocysteine concentrations in neuronal-like cells","volume":"39","author":"M Curro","year":"2014"},{"issue":"5","key":"ref7","first-page":"721","article-title":"Obesity and insulin resistance associated with lower plasma vitamin B12 in PCOS","volume":"19","author":"C Kaya","year":"2009"},{"issue":"2","key":"ref8","first-page":"314","article-title":"Hyperhomocysteinaemia is associated with biochemical hyperandrogenaemia in women with reproductive age","volume":"171","author":"YH Lin","year":"2013"},{"issue":"6","key":"ref9","first-page":"741","article-title":"Meta-analysis of cardiovascular disease risk markers in women with polycystic ovary syndrome","volume":"17","author":"KA Toulis","year":"2011"},{"issue":"3","key":"ref10","first-page":"268","article-title":"Circulating markers of oxidative stress and polycystic ovary syndrome (pcos): A systematic review and meta-analysis","volume":"19","author":"M Murri","year":"2013"},{"issue":"1","key":"ref11","first-page":"1","article-title":"Apolipoprotein e gene polymorphism and polycystic ovary syndrome patients in Western Anatolia, Turkey","volume":"26","author":"S Cetinkalp","year":"2009"},{"key":"ref12","doi-asserted-by":"crossref","DOI":"10.1210\/jc.2007-0842","article-title":"Asymmetrical dimethylarginine, inflammatory and metabolic parameters in women with polycystic ovary syndrome before and after metformin treatment","author":"D Heutling","year":"2008"},{"issue":"4","key":"ref13","first-page":"278","article-title":"Cardiovascular disease markers in women with polycystic ovary syndrome with emphasis on asymmetric dimethylarginine and homocysteine","volume":"30","author":"AM Mohamadin","year":"2010"},{"key":"ref14","first-page":"387","article-title":"Cardiovascular risk factors in polycystic ovary syndrome","volume":"30","author":"A Karaer","year":"2010"},{"issue":"2","key":"ref15","first-page":"151","article-title":"Cardiovascular risk in women with polycystic ovarian syndrome (PCOS)","volume":"58","author":"AST Bickerton","year":"2005"},{"issue":"9","key":"ref16","first-page":"505","article-title":"Chronic inflammation and elevated homocysteine levels are associated with increased body mass index in women with polycystic ovary syndrome","volume":"23","author":"K Guzelmeric","year":"2007"},{"issue":"1","key":"ref17","first-page":"230","article-title":"C-reactive protein and homocysteine levels are associated with abnormal heart rate recovery in women with polycystic ovary syndrome","volume":"94","author":"C Kaya","year":"2010"},{"issue":"3","key":"ref18","first-page":"511","article-title":"Diastolic dysfunction and increased serum homocysteine concentrations may contribute to increased cardiovascular risk in patients with polycystic ovary syndrome","volume":"76","author":"H Yarali","year":"2001"},{"issue":"4","key":"ref19","first-page":"930","article-title":"Do young women with polycystic ovary syndrome show early evidence of preclinical coronary artery disease?","volume":"21","author":"S Topcu","year":"2006"},{"issue":"6","key":"ref20","first-page":"1864","article-title":"The effect of serum and intrafollicular insulin resistance parameters and homocysteine levels of nonobese, nonhyperandrogenemic polycystic ovary syndrome patients on in vitro fertilization outcome","volume":"93","author":"Y Nafiye","year":"2010"},{"issue":"6","key":"ref21","first-page":"904","article-title":"The effects of metformin on metabolic and cardiovascular risk factors in nonobese women with polycystic ovary syndrome","volume":"67","author":"Y Sahin","year":"2007"},{"issue":"12","key":"ref22","first-page":"3333","article-title":"The effects of rosiglitazone and metformin on oxidative stress and homocysteine levels in lean patients with polycystic ovary syndrome","volume":"20","author":"M Yilmaz","year":"2005"},{"issue":"4","key":"ref23","first-page":"168","article-title":"Evaluation of homocysteine levels in patients with polycystic ovarian syndrome","volume":"4","author":"S Salehpour","year":"2011"},{"issue":"3","key":"ref24","first-page":"223","article-title":"High plasma homocysteine and insulin resistance in patients with polycystic ovarian syndrome","volume":"9","author":"T Hemati","year":"2011"},{"issue":"4","key":"ref25","first-page":"211","article-title":"Homocysteine and Ghrelin Link with Polcystic Ovary Syndrome in Relation to Obesity","volume":"24","author":"T Altu\u011d \u015een","year":"2011"},{"issue":"2","key":"ref26","first-page":"673","article-title":"Homocysteine levels and C677T polymorphism of methylenetetrahydrofolate reductase in women with polycystic ovary syndrome","volume":"88","author":"F Orio Jr","year":"2003"},{"issue":"3","key":"ref27","first-page":"406","article-title":"Increased arterial stiffness in nonobese women with polycystic ovary syndrome (PCOS) without comorbidities: One more characteristic inherent to the syndrome?","volume":"71","author":"GM Soares","year":"2009"},{"issue":"1","key":"ref28","first-page":"310","article-title":"Ischemia-modified albumin and cardiovascular risk markers in polycystic ovary syndrome with or without insulin resistance","volume":"95","author":"GS Caglar","year":"2011"},{"issue":"1","key":"ref29","first-page":"127","article-title":"Methylenetetrahydrofolate reductase C677T gene polymorphism in turkish patients with polycystic ovary syndrome","volume":"38","author":"M Karadeniz","year":"2010"},{"key":"ref30","article-title":"A Nonrandomized Trial of Progressive Resistance Training Intervention in Women With Polycystic Ovary Syndrome and Its Implications in Telomere Content","author":"CL Miranda-Furtado","year":"2015"},{"issue":"5","key":"ref31","first-page":"474","article-title":"Obesity-related lipid profile and altered insulin incretion in adolescents with polycystic ovary syndrome","volume":"46","author":"A Fulghesu","year":"2010"},{"issue":"1","key":"ref32","first-page":"120","article-title":"Oral contraceptive plus antiandrogen therapy and cardiometabolic risk in polycystic ovary syndrome","volume":"78","author":"A Harmanci","year":"2013"},{"issue":"6","key":"ref33","first-page":"373","article-title":"Oxidative stress and anti-oxidant defense system in Iranian women with polycystic ovary syndrome","volume":"13","author":"M Moti","year":"2015"},{"issue":"11","key":"ref34","first-page":"874","article-title":"Paraoxonase lactonase activity (PON-HTLase), asymmetric dimethylarginine (ADMA) and platelet activating factor-acetylhydrolase (PAF-AH) activity in non-obese women with PCOS","volume":"28","author":"T Bayrak","year":"2012"},{"issue":"6","key":"ref35","first-page":"601","article-title":"Plasma homocysteine levels in polycystic ovary syndrome and congenital adrenal hyperplasia","volume":"51","author":"F Bayraktar","year":"2004"},{"issue":"5","key":"ref36","first-page":"505","article-title":"Relationship between homocysteine and insulin resistance in women with polycystic ovary syndrome","volume":"51","author":"T Kilic-Okman","year":"2004"},{"issue":"8","key":"ref37","first-page":"602","article-title":"Serum brain natriuretic peptide and C-reactive protein levels in adolescent with polycystic ovary syndrome","volume":"28","author":"R Deveer","year":"2012"},{"issue":"1","key":"ref38","first-page":"96","article-title":"Serum levels of leptin and homocysteine in women with polycystic ovary syndrome and its relationship to endocrine, clinical and metabolic parameters","volume":"36","author":"A Atamer","year":"2008"},{"issue":"2","key":"ref39","first-page":"221","article-title":"Serum nonesterified fatty acids, ghrelin, and homocysteine levels in women with polycystic ovary syndrome","volume":"40","author":"I Temel","year":"2010"},{"issue":"3","key":"ref40","first-page":"161","article-title":"Serum resistin and adiponectin levels in young non-obese women with polycystic ovary syndrome","volume":"26","author":"S Arikan","year":"2010"},{"issue":"2","key":"ref41","first-page":"31","article-title":"Status of homocysteine in polycystic ovary syndrome","volume":"8","author":"P Maleedhu","year":"2014"},{"issue":"2 Pt 1","key":"ref42","first-page":"385","article-title":"Vascular risk in young women with polycystic ovary and polycystic ovary syndrome","volume":"111","author":"C Battaglia","year":"2008"},{"issue":"6","key":"ref43","first-page":"2545","article-title":"Polycystic ovary syndrome is associated with elevated plasma soluble CD40 ligand, a marker of coronary artery disease","volume":"91","author":"M Oktem","year":"2009"},{"issue":"9","key":"ref44","first-page":"541","article-title":"Efficacy of metformin in patients with non-insulin-dependent diabetes mellitus. The Multicenter Metformin Study Group","volume":"333","author":"RA DeFronzo","year":"1995"},{"issue":"8967","key":"ref45","first-page":"85","article-title":"Effects of vitamin B12, folate, and vitamin B6 supplements in elderly people with normal serum vitamin concentrations","volume":"346","author":"HJ Naurath","year":"1995"},{"key":"ref46","article-title":"Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement","volume":"339","author":"D Moher","year":"2009"},{"issue":"1","key":"ref47","first-page":"19","article-title":"Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome","volume":"81","year":"2004"},{"key":"ref48","first-page":"377","article-title":"Diagnostic criteria for polycystic ovary syndrome: towards a rational approach","author":"J Zawadzki","year":"1992"},{"issue":"11","key":"ref49","first-page":"4237","article-title":"Positions statement: criteria for defining polycystic ovary syndrome as a predominantly hyperandrogenic syndrome: an Androgen Excess Society guideline","volume":"91","author":"R Azziz","year":"2006"},{"key":"ref50","unstructured":"Wells G, Shea B, O\u2019connell D, Peterson J, Welch V, Losos M, Tugwell P: The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. In.; 2000."},{"issue":"7109","key":"ref51","first-page":"629","article-title":"Bias in meta-analysis detected by a simple, graphical test","volume":"315","author":"M Egger","year":"1997"},{"issue":"2","key":"ref52","first-page":"74","article-title":"Homocysteine and steroids levels in metformin treated women with polycystic ovary syndrome","volume":"110","author":"J Vrbikova","year":"2002"},{"issue":"6","key":"ref53","first-page":"1521","article-title":"Administration of B-group vitamins reduces circulating homocysteine in polycystic ovarian syndrome patients treated with metformin: a randomized trial","volume":"20","author":"EB Kilicdag","year":"2005"},{"issue":"1","key":"ref54","first-page":"227","article-title":"Prospective, randomized trial of metformin and vitamins for the reduction of plasma homocysteine in insulin-resistant polycystic ovary syndrome","volume":"88","author":"M Schachter","year":"2007"},{"issue":"1","key":"ref55","first-page":"32","article-title":"Metabolic and endocrine effects of metformin and metformin plus cyclic medroxyprogesterone acetate in women with polycystic ovary syndrome","volume":"105","author":"B Haydardedeoglu","year":"2009"},{"issue":"4","key":"ref56","first-page":"273","article-title":"Effect of lifestyle modification and metformin therapy on emerging cardiovascular risk factors in overweight Indian women with polycystic ovary syndrome","volume":"10","author":"G Rajagopal","year":"2012"},{"issue":"4","key":"ref57","first-page":"211","article-title":"Homocysteine and ghrelin link with polcystic ovary syndrome in relation to obesity","volume":"24","author":"T Altug Sen","year":"2011"},{"issue":"2","key":"ref58","first-page":"133","article-title":"Body composition characteristics are associated with the bone density of the proximal femur end in middle- and old-aged women and men","volume":"39","author":"S Kirchengast","year":"2001"},{"issue":"3","key":"ref59","first-page":"263","article-title":"Biological and environmental determinants of plasma homocysteine","volume":"26","author":"J Schneede","year":"2000"},{"issue":"1","key":"ref60","first-page":"33","article-title":"Polycystic ovary syndrome and the single nucleotide polymorphisms of methylenetetrahydrofolate reductase: a pilot observational study","volume":"10","author":"M Palep-Singh","year":"2007"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0157389","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,10,22]],"date-time":"2018-10-22T14:22:40Z","timestamp":1540218160000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0157389"}},"subtitle":[],"editor":[{"given":"Wan-Xi","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2016,6,9]]},"references-count":60,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2016,6,9]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0157389","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,6,9]]}}}